NEW YORK, NY – As October arrives, the world often turns a familiar shade of pink to mark Breast Cancer Awareness Month. Yet, for thousands of families, the standard narrative of early detection and successful treatment completion tells only half the story. On October 13, National Metastatic Breast Cancer (MBC) Awareness Day, a global coalition is shifting the focus toward the most critical, underfunded, and life-altering aspect of the disease: Stage 4 metastatic breast cancer.
Through the #LightUpMBC campaign, more than 325 landmarks across 20 countries, 195 cities, and all 50 U.S. states will glow in the vibrant colors of teal, green, and pink. This synchronized illumination is not merely a visual spectacle; it is a profound act of defiance against a terminal diagnosis, serving as a beacon of hope, a memorial for those lost, and a powerhouse for critical research funding.
The Reality of Stage 4: Defining the Invisible Struggle
Metastatic breast cancer occurs when cancer cells migrate from the breast to distant organs—most commonly the bones, liver, lungs, or brain. Despite the name, it remains breast cancer regardless of where it resides in the body. The clinical reality is stark: while some patients are diagnosed at Stage 4 from the outset, others may receive a metastatic diagnosis months, years, or even decades after completing treatment for early-stage disease.
Unlike earlier stages of breast cancer, which are often treated with the goal of being "cured," MBC is currently incurable. Patients diagnosed with this condition are in a state of perpetual treatment. Even when clinical scans show "no evidence of disease," the cancer remains present, requiring ongoing therapeutic intervention to control growth and preserve quality of life. As the disease progresses, it often becomes resistant to existing therapies, forcing patients to constantly navigate the physical and emotional toll of changing treatment regimens.
The statistics are sobering. In the United States alone, an estimated 42,670 people are projected to die from breast cancer in 2026—a harrowing average of 117 deaths every single day. This data underscores a fundamental truth: research is not a luxury; it is a life-saving necessity.
Chronology of a Global Movement
The #LightUpMBC campaign traces its roots to a deeply personal origin story that has since evolved into a worldwide phenomenon.
2017: The First Spark
The movement began in New Hampshire, where the Portsmouth Memorial Bridge became the first landmark to be illuminated in the colors of metastatic breast cancer awareness. It was a modest, localized tribute, yet it carried the seeds of a much larger mission.
2018–2022: Scaling the Mission
Recognizing the power of visual advocacy, the initiative began to expand. Founder Laura Inahara, motivated by the loss of her best friend, Jessica Moore—who passed away from MBC at age 36—worked tirelessly to turn Moore’s original dream of lighting a single local landmark into a global effort. Year by year, the map grew, crossing borders and oceans to reach major international hubs.
2026: A Unifying Moment
Today, the campaign boasts participation from some of the most iconic structures in the world, including New York’s One World Trade Center, Chicago’s Willis Tower, Philadelphia’s City Hall, the majestic Niagara Falls, and the Ness Bridge in Scotland. This growth represents a shift in public consciousness, moving from passive awareness to active, organized advocacy.
Bridging the Gap: METAvivor’s Scientific Mandate
The primary beneficiary of #LightUpMBC is METAvivor Research and Support, a 501(c)(3) nonprofit that occupies a unique space in the oncology landscape. Unlike many larger breast cancer organizations that divide their resources across prevention, screening, and survivorship, METAvivor exclusively funds Stage 4 metastatic breast cancer research.
The organization employs a rigorous, two-tiered review process. Each grant proposal is evaluated by a panel of scientific experts to ensure technical feasibility and clinical merit, and by a group of patient advocates who ensure the research remains centered on the needs of those living with the disease. This dual-vetting process ensures that every dollar raised goes toward projects with the highest potential to transform MBC from a terminal diagnosis into a chronic, survivable condition with a high quality of life.
To date, the #LightUpMBC initiative has raised over $2.7 million, directly fueling high-impact research projects that might otherwise struggle to find funding.
Voices from the Frontlines: Official Perspectives
The movement is driven by those who understand the urgency of the cause on a personal level. Dr. Kelly Shanahan, the Board President of METAvivor, has lived with an MBC diagnosis since 2013.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan noted in a recent statement. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and it is also a way to bring us together as a community."
Laura Inahara, the founder of the campaign, emphasizes the legacy of her late friend, Jessica Moore. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has now raised millions for critical research."
LightUpMBC Live: The 2026 Program
To further the educational mission, #LightUpMBC will host its annual live broadcast on Tuesday, October 13, at 8 p.m. ET / 5 p.m. PT. Hosted by Tami Eagle Bowling—who has lived with MBC for 11 years—and Broadway performer and breast cancer survivor Kara Lindsay, the event is designed to be as informative as it is emotionally resonant.
The program will feature:
- Patient Stories: Live testimonials from those currently navigating the metastatic experience, broadcasting from various illuminated landmarks.
- Scientific Insights: Expert perspectives on the latest breakthroughs in MBC research and the future of treatment protocols.
- Artistic Tributes: Performances by two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, singer-songwriter Cassandra Kubinski, and voiceover artist Tony Daniels.
The livestream will be available for free on the METAvivor YouTube channel and METAvivor’s Facebook Live page, with additional streaming support via LiveOne.
Implications: Turning Awareness into Action
The success of the #LightUpMBC campaign serves as a critical reminder that advocacy is not just about wearing a ribbon; it is about systemic change. By funding research that addresses the unique biological complexities of metastatic disease, the initiative is chipping away at the mortality rate of a condition that has historically been ignored by broader health initiatives.
The implications for patients are significant. Increased funding allows for more clinical trials, faster development of precision medicine, and better supportive care options. Moreover, the visibility provided by the lighting of hundreds of landmarks serves to destigmatize the conversation around terminal illness. It invites the public to look past the pink-ribbon culture of "early detection" and face the reality of the metastatic community, fostering a more inclusive and informed approach to healthcare policy and philanthropy.
How to Get Involved
The public is encouraged to participate in several ways:
- Visit and Share: Capture photos of participating landmarks in your area. Share these images on social media using the hashtags #LightUpMBC and #METAVivor, and tag @LightUpMBC.
- Attend the Stream: Tune in to the #LightUpMBC Live broadcast on October 13 to hear firsthand accounts from the community and leading researchers.
- Support the Cause: One hundred percent of the net proceeds from the #LightUpMBC campaign go directly to funding Stage 4 research. Donations and a full list of participating landmarks can be found at www.lightupmbc.org.
As the sun sets on October 13, these hundreds of landmarks will serve as a glowing testament to the resilience of the human spirit. They stand for the patients who are fighting, the researchers who are searching for answers, and the families who are honoring the memories of those lost. In the silence of the night, the light provides a powerful answer to the question of what can be done: everything.
About the Author
